61
Growth Score
pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
435884
Apaxen develops treatment for chronic NLRP3 inflammasome activation and macrophage migration inhibitory factor.
About the Company
Apaxen is a company that creates anti-inflammatory medicines to treat pulmonary arterial hypertension. The business focuses on finding and creating suitable small molecule inhibitors of macrophage migration inhibitory factor, which is essential for the creation and activation of NLRP3 inflammasomes. Its drug candidate, MFC-1040, is an orally
bioavailable and selective small-molecule MIF inhibitor that is being developed to treat pulmonary arterial hypertension, a deadly illness with a medical need because current treatments are symptomatic and have a low median survival rate.
